Irinotecan Hydrochloride Injection — FDA Drug Shortage

No longer listed by FDA — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

The FDA lists a drug shortage record for Irinotecan Hydrochloride Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status No longer listed by FDA. The shortage was first posted on Sep 26, 2025.

Shortage details

Status
No longer listed by FDA
Company
Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Package NDC
25021-230-02
Dosage Form
Injection
Presentation
Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 25021-230-02)
Initial Posting
Sep 26, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.